NEW YORK, Nov. 30, 2016 -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Tenet Healthcare Corp. securities (NYSE:THC) from February 28, 2012 through October 3, 2016, both dates inclusive (the “Class Period”) of the important December 6, 2016 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks recovery of investor losses.
To join the Tenet class action, go to http://www.rosenlegal.com/cases-963.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Tenet illegally paid kickbacks to induce the referral of patients to Tenet’s hospitals for labor and delivery; (2) through this scheme, Tenet defrauded the Georgia Medicaid program; and (3) as a result, defendants’ statements about Tenet’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 6, 2016. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-963.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected]. Attorney Advertising. Prior results do not guarantee a similar outcome.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



